Barrier functionality and transport machineries of human ECV304 cells

Area of Science:

• Pharmacology
• Cell Biology
• Biotechnology

Background:

• The ECV304 cell line, initially identified as endothelial, was widely used for blood-brain barrier (BBB) research.
• It was later discovered to be T24 bladder carcinoma epithelial cells, necessitating re-evaluation for in vitro BBB models.
• This study investigates ECV304 cells' potential for drug screening and transport studies.

Purpose of the Study:

• To assess the barrier properties and plasma membrane characteristics of ECV304 cells.
• To evaluate their suitability as an in vitro model for drug permeability screening.
• To determine the functionality of key transporters and endocytic machineries.

Main Methods:

• ECV304 cells were treated with tight-junction modulators, including astrocytic factors and cAMP elevators.
• Bioelectrical resistance (TEER) and permeability coefficients for transcellular and paracellular markers were measured.
• Functional expression of carrier-mediated transporters and endocytic pathways was assessed.

Main Results:

• Tight-junction modulation increased trans-endothelial electrical resistance (TEER) to approximately 110 Omega*cm2.
• High discrimination was observed between transcellular (propranolol) and paracellular (sucrose) marker permeability.
• Functional expression of transporters like GLUT-1, system L, P-glycoprotein (P-gp), and endocytic machineries was confirmed.

Conclusions:

• ECV304 cells do not form a sufficiently tight barrier for reliable drug permeability screening.
• Despite barrier limitations, ECV304 cells express crucial carrier-mediated transport systems.
• These cells can be considered a valuable in vitro model for studying transport mechanisms.